Biomaterial Database

Anabolic Therapy for Osteoporosis. 2021

Kristine E Ensrud, and John T Schousboe

Division of Epidemiology & Community Health, Department of Medicine, University of Minnesota, Minneapolis.

UI	MeSH Term	Description	Entries
D010024	Osteoporosis	Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.	Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077264	Calcium-Regulating Hormones and Agents	Hormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis.	Calcium-Regulating Hormones,Calcium Regulating Hormones,Calcium Regulating Hormones and Agents,Hormones, Calcium-Regulating
D000911	Antibodies, Monoclonal	Antibodies produced by a single clone of cells.	Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D044162	Parathyroid Hormone-Related Protein	A ubiquitously expressed, secreted protein with bone resorption and renal calcium reabsorption activities that are similar to PARATHYROID HORMONE. It does not circulate in appreciable amounts in normal subjects, but rather exerts its biological actions locally. Overexpression of parathyroid hormone-related protein by tumor cells results in humoral calcemia of malignancy.	Hypercalcemic Hormone of Malignancy,PTH Like Tumor Factor,PTH-Like Protein,PTH-Related Peptide,PTHrP,Parathyroid Hormone Like Tumor Factor,Parathyroid Hormone-Like Protein,Parathyroid Hormone-Related Peptide,Tumor Hypercalcemic Factor,Hormone-Related Protein, Parathyroid,Hypercalcemic Factor, Tumor,PTH Like Protein,PTH Related Peptide,Parathyroid Hormone Like Protein,Parathyroid Hormone Related Peptide,Parathyroid Hormone Related Protein
D045930	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power.	Anabolic Effect,Anabolic Effects,Agents, Anabolic,Effect, Anabolic,Effects, Anabolic
D050071	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.	Antiresorptive Agent,Antiresorptive Agents,Antiresorptive Drugs,Bone Resorption Inhibitors,Bone Resorption Inhibitory Agents,Agent, Antiresorptive,Inhibitors, Bone Resorption,Resorption Inhibitors, Bone
D019379	Teriparatide	A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)	Human Parathyroid Hormone (1-34),hPTH (1-34),Forteo,Parathar,Teriparatide Acetate